Literature DB >> 19609911

TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea.

Gabor G Kovacs1, Jill R Murrell, Sandor Horvath, Laszlo Haraszti, Katalin Majtenyi, Maria J Molnar, Herbert Budka, Bernardino Ghetti, Salvatore Spina.   

Abstract

TDP-43 has been identified as the pathological protein in the majority of cases of frontotemporal lobar degeneration and amyotrophic lateral sclerosis (ALS). TARDBP mutations have so far been uniquely associated with familial and sporadic ALS. We describe clinicopathological and genetic findings in a carrier of the novel K263E TARDBP variation, who developed frontotemporal dementia, supranuclear palsy, and chorea, but no signs of motor neuron disease. Neuropathologic examination revealed neuronal and glial TDP-43-immunoreactive deposits, predominantly in subcortical nuclei and brainstem. This is the first report of a TARDBP variation associated with a neurodegenerative syndrome other than ALS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609911     DOI: 10.1002/mds.22697

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  96 in total

Review 1.  TDP-43 aggregation in neurodegeneration: are stress granules the key?

Authors:  Colleen M Dewey; Basar Cenik; Chantelle F Sephton; Brett A Johnson; Joachim Herz; Gang Yu
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

Review 2.  Advances in understanding the molecular basis of frontotemporal dementia.

Authors:  Rosa Rademakers; Manuela Neumann; Ian R Mackenzie
Journal:  Nat Rev Neurol       Date:  2012-06-26       Impact factor: 42.937

Review 3.  TAR DNA-binding protein 43 in neurodegenerative disease.

Authors:  Alice S Chen-Plotkin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurol       Date:  2010-03-16       Impact factor: 42.937

4.  An algorithm for genetic testing of frontotemporal lobar degeneration.

Authors:  J S Goldman; R Rademakers; E D Huey; A L Boxer; R Mayeux; B L Miller; B F Boeve
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

Review 5.  Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.

Authors:  T F Gendron; K A Josephs; L Petrucelli
Journal:  Neuropathol Appl Neurobiol       Date:  2010-02-19       Impact factor: 8.090

6.  A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD.

Authors:  Giuseppe Borghero; Gianluca Floris; Antonino Cannas; Maria G Marrosu; Maria R Murru; Emanuela Costantino; Leslie D Parish; Maura Pugliatti; Anna Ticca; Bryan J Traynor; Andrea Calvo; Stefania Cammarosano; Cristina Moglia; Angelina Cistaro; Maura Brunetti; Gabriella Restagno; Adriano Chiò
Journal:  Neurobiol Aging       Date:  2011-07-30       Impact factor: 4.673

7.  Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene.

Authors:  Adriano Chiò; Giuseppe Borghero; Maura Pugliatti; Anna Ticca; Andrea Calvo; Cristina Moglia; Roberto Mutani; Maura Brunetti; Irene Ossola; Maria Giovanna Marrosu; Maria Rita Murru; Gianluca Floris; Antonino Cannas; Leslie D Parish; Paola Cossu; Yevgeniya Abramzon; Janel O Johnson; Michael A Nalls; Sampath Arepalli; Sean Chong; Dena G Hernandez; Bryan J Traynor; Gabriella Restagno
Journal:  Arch Neurol       Date:  2011-01-10

Review 8.  Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism.

Authors:  Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  J Mol Neurosci       Date:  2011-06-08       Impact factor: 3.444

Review 9.  Extrapyramidal syndromes in frontotemporal degeneration.

Authors:  Andrew Kertesz; Paul McMonagle; Sarah Jesso
Journal:  J Mol Neurosci       Date:  2011-09-02       Impact factor: 3.444

Review 10.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.